Search Results
Results found for "Gregory D Stewart"
- Dr. Gregory Tall | Dr. GPCR Ecosystem
Gregory Tall About Dr. Gregory Tall " Dr. Gregory Tall earned his Ph.D. in Biomedical Sciences from U.T. Gregory Tall on the web The Tall Lab University of Michigan Google Scholar Twitter Dr.
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Pan, Michael Holinstat and Gregory G. Gregory Tall and our research primarily focuses on the structural and biochemical characterization of
- Do you know that dilated cardiomyopathy, a disease that makes it harder for the heart to pump blood to the rest of the body, results from the deficiency of Latrophilin-2? Check out this paper to understand the function of Latrophilin-2 and how it leads to dilated cardiomyopathy. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. | Dr. GPCR Ecosystem
gpcrs-in-cardiology-endocrinology-and-taste/latrophilin-2-deletion-in-cardiomyocyte-disrupts-cell-junction%2C-leading-to-d-cmp
- How GPCR Collaboration Built an Innovation Engine | Dr. GPCR Ecosystem
Created a durable innovation hub This is more than a story — it’s a blueprint for GPCR science, biotech R&D,
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
behind pH Sense, Revvity’s innovative GPCR internalization assay, and his journey in GPCR product R&D. Eric Trinquet is Head of R&D for Life Sciences Reagents at Revvity, where he leads innovation in biochemical
- ama session sept 18 post 2 | Dr. GPCR Ecosystem
Pharmacology #DrugDiscovery #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D
- Dr. Juan José Fung | Dr. GPCR Ecosystem
discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D
- Annabelle Milner | Dr. GPCR Ecosystem
In particular, she is looking at L- and D-lactate-activated HCAR1 signaling.
- ama session sept 18 post 1 | Dr. GPCR Ecosystem
#DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Leipzig, Germany 2 Institute of Medical Physics and Biophysics, Leipzig University, Härtelstr. 16-18, D- Rudolf-Schönheimer-Institute of Biochemistry, Division of General Biochemistry, Leipzig University, Johannisallee 30, D- Rudolf-Schönheimer-Institute of Biochemistry, Division of Molecular Biochemis-try, Leipzig University, Johannisallee 30, D-
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
Yamina Berchiche on the web D r.
- Vaithish Velazhahan | Dr. GPCR Ecosystem
His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
Following this, he joined an early-stage medical device start-up and in 5 years was responsible for project R&D and managing a focused development team, pursued international strategic partnerships, managed IP
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
I work with invertebrate animal models (mainly D. melanogaster) and in vitro techniques to pick apart
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
I have 10 years of experience in the development and management of R&D projects and teams in the field Sciences from the University of Lausanne, Switzerland, Department of Biochemistry (2005-2009), where I started And since then, my incredible adventure as CEO of this fast-growing company started and is continuing
- Dr. Chris Tate | Dr. GPCR Ecosystem
In 2005 he started working on the development of conformational thermostabilization of GPCRs, which resulted of a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D
- Chris Langmead | Dr. GPCR Ecosystem
He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
to the GPCR field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D
- Yamina's Corner | Dr. GPCR Ecosystem
Optimized CRO Collaboration: Streamline internal R&D and external CRO workflows to prevent delays and focused execution accelerates preclinical milestones and maximizes the efficiency and return on your R&D
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
, Kim JH, Jeong K, Murphy JM, Harvey CA, Dunlap S, Gehrs L, Lee H, Kim HG, Sah JP, Lee SN, Stanford D, Two major types of mRNAs were identified in human/mouse brain, those with a start codon in exon 2 encoding a full-length protein of a predicted size of 173.5/173.3 kDa and shorter transcripts starting from alternative exons at the intron 17/exon 18 boundary with new or exon 19 start codons, predicting shorter isoforms Attendees Authors & Affiliations "Gandhi, Riya; Chandan, Nancy; Kwarcinski, Frank; Smrcka, Alan; and Tall, Gregory
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
chemists and structural biologists Early-career researchers exploring drug discovery Biotech leaders and R&D
- Revvity | Dr. GPCR Ecosystem
Revvity, Eric worked for Cisbio Bioassays first as Director of Technological Development and then as R&D Elodie DUPUIS R&D Senior project manager, team leader.
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in
- Dr. GPCR Board | Dr. GPCR Ecosystem
My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed me to shape a swiss start-up company from a scientifc idea to a thriving Biotech focusing on Systems
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Kwarcinski, Gregory G. Mariam started her postdoctoral training in February 2024 and is hoping to become an academic professor
- A GPCR imaging breakthrough that didn’t start in a grant proposal | Dr. GPCR Ecosystem
Home → Flash News → A GPCR imaging breakthrough that didn’t start in a grant proposal A GPCR imaging breakthrough that didn’t start in a grant proposal Published on December 3, 2025 Category It started




















